Fifth Lane Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Fifth Lane Capital’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,000	Closed	-$501K	–	285
2023 Q2	$501K	Buy	+14,000	New	+$494K	0.15%	60

Fifth Lane Capital's ISEE Position: Q3 2023 in Review

Fifth Lane Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 23,000 shares — an estimated $905K sold.

Fifth Lane Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $905K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Fifth Lane Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Fifth Lane Capital sold 23,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $905K.
Fifth Lane Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Fifth Lane Capital's IVERIC bio, Inc. Common Stock position peaked at $905K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Fifth Lane Capital's 13F filing for Q3 2023, filed 14 Nov 2023.